Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction



Rating:

Share or cite this content

Citations should be made in the following way:
D. Rozeveld, S. van der Heide, R. Bischoff, W. van der Bij, A. van Oosterhout, I. Heijink, M. van der Toorn (Groningen, Netherlands). Aberrant metalloprotease expression and activity in bronchoalveolar lavage fluid of bronchiolitis obliterans patients. Eur Respir J 2013; 42: Suppl. 57, 363

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory markers in serum and lavage fluid in young adult’s patients with postinfectious bronchiolitis obliterans Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Elastase and α1-proteinase inhibitor in bronchoalveolar lavage fluid of children with chronic bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 181s Year: 2001 Characterization of inflammation in bronchoalveolar lavage of lung transplant patients Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Activity of neutrophils in bronchoalveolar lavage fluid in children with chronic bronchiolitis and asthma Source: Eur Respir J 2001; 18: Suppl. 33, 272s Year: 2001 Different expression of CD44variant6 in BAL mesenchymal cells is related to BOS severity Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Cathelicidin (LL-37) ve human β2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The effect of MUC5B promoter polymorphism on susceptibility to idiopathic interstitial pneumonias and cell profiles in bronchoalveolar Lavage fluid Source: International Congress 2015 – IPF pathogenesis Year: 2015 Bronchoalveolar lavage (BAL) in the differential diagnosis of sarcoidosis, extrinsic allergic alveolitis and BOOP Source: Eur Respir J 2003; 22: Suppl. 45, 255s Year: 2003 Importance of early bronchoalveolar lavage in immunocompromised patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia Source: International Congress 2014 – ILDs 2 Year: 2014 The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Bronchoalveolar lavage in children with diffuse lung disease Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease Year: 2008 Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis Source: Eur Respir J 2003; 21: 144-148 Year: 2003 Serum and bronchoalveolar exosomal miRNAs in pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Chemokine concentrations in bronchoalveolar lavage (BAL) in asthma and eosinophilic bronchitis Source: Annual Congress 2004 - Immunology of airway and pulmonary disease Year: 2004 Utility of bronchoalveolar lavage in vasculitis patients Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014